The BIOTECH media, unfolded.
Biotechnology, gene editing, neurotech and computational biology.
123 reports across 1 topic, updated hourly.
Moderna co-founder Kenneth Chien, reflecting on his 50-year scientific career, highlighted an Hermes belt gifted by Moderna CEO Stéphane Bancel in 2013. This gift followed Chien's instrumental role in securing a significant partnership between the nascent mRNA startup Moderna…
Edison Scientific, an AI scientist company, has been engaged by Metsera to develop new biotechnology ventures. The company, founded in late 2025 with $70 million in venture funding, aims to accelerate scientific discovery by providing scientists with autonomous AI agents.
A review published online in Nature on June 24, 2026, explores the immunological mechanisms of mRNA–lipid-nanoparticle vaccines for infectious diseases. The research highlights how specific components within this vaccine platform can be precisely adjusted to elicit tailored immune responses…
Scientists utilized an advanced genome-editing tool in early human embryos to investigate the function of a key gene in early development, according to research published in Nature on Thursday. This next-generation CRISPR technology demonstrated enhanced precision and reduced damage compared…
Congress passed a bill last year to restrict U.S. pharmaceutical and biotechnology companies' business dealings with Chinese firms, but many lawmakers are seeking further measures. These efforts aim to counter the growth of Chinese biopharma companies through additional legislative…
A patent granted in the 1970s for recombinant DNA technology, a foundational technique in genetic engineering, is being recognized for its profound impact on the commercial biotechnology sector. This patent, filed by scientists Stanley Cohen and Herbert Boyer, enabled…
STAT+ reported on significant AI developments discussed at a biotech conference in San Diego this week. The newsletter, a subscriber-exclusive guide to artificial intelligence in health care and medicine, highlighted a "crazy story" that executive editor Rick Berke shared…
Regenxbio announced on Wednesday that it will seek accelerated approval for its gene therapy targeting Duchenne muscular dystrophy. This decision follows a statement made by the company just one month prior, indicating that regulatory bodies required an additional trial…
Serapha Bio launched on Tuesday with $230 million in funding and a licensing deal with a Chinese drug company, aiming to develop a one-and-done treatment for Alpha-1 Antitrypsin Deficiency (AATD).
STAT+ reported that pharmaceutical companies are actively engaging in mergers and acquisitions within the biotechnology sector, signaling a resurgence in biotech M&A activity. This trend is underscored by significant deals and a general increase in acquisition interest.
The Food and Drug Administration (FDA) will reconsider approving Regenxbio's experimental gene therapy for mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, a rare and fatal childhood brain disorder.
Pharmaceutical companies have significantly increased their acquisition activity, completing 32 biotech acquisitions valued at $1 billion or more in the past six months. This surge in deal-making has resulted in approximately $123 billion being spent by pharmaceutical and large biotech…
Casey Harrell, a man diagnosed with ALS, is the first "power user" of a brain-computer interface (BCI) that allows him to communicate and perform tasks despite paralysis. Harrell, who has been using the BCI since July 2023, can now "speak"…
A panel of advisers to the Food and Drug Administration endorsed Moderna's seasonal mRNA flu vaccine on Thursday, marking a significant step after the vaccine faced controversy earlier this year when a top agency official initially refused to review it.
A brain implant has enabled a man with motor neuron disease (MND) to regain aspects of his daily life by facilitating communication and computer control for nearly two years. The device, detailed in a publication on June 15, 2026, utilizes…
STAT+ reported on a biotechnology company that leveraged an artificial intelligence model to re-evaluate a failed clinical trial, leading to new insights. The company, whose name was not explicitly stated in the provided text, utilized AI to analyze extensive datasets…
Casey Harrell, a man diagnosed with ALS, has become the first "power user" of a brain-computer interface (BCI) designed to restore speech. Harrell, who has been using the implanted electrodes for nearly three years, first utilized the device to communicate…
Casey Harrell, a man with amyotrophic lateral sclerosis (ALS), has become the first "power user" of a brain-computer interface (BCI) that enables him to communicate and perform daily tasks. Harrell, who has been paralyzed and dependent on others for care…